As we have previously reported, the use of Pradaxa has been linked to serious injury. There are nearly 600 cases currently pending in federal court. The lawsuits allege that Pradaxa, manufactured by Boehringer Ingelheim, Inc., has resulted in devastating and sometimes fatal outcomes. Pradaxa is a blood thinner that was marketed to replace warfarin, a commonly used anticoagulant. Unfortunately, there is no readily-available antidote for the internal bleeding that can sometimes occur in patients treated with Pradaxa.
Plaintiffs’ counsel in the Multi District Litigation (MDL) pending in Chicago, Illinois has successfully argued for the production of certain Boehringer Ingelheim’s employee personnel records. The recent Court Order directs the company to disclose employee reviews and bonuses related to Pradaxa for company witnesses that played a role in the development, approval or marketing of the drug.
The devastating consequences of Pradaxa use will likely continue. If you or a loved one has experienced serious side effects after taking Pradaxa, you can contact Stark & Stark and speak to one of the Mass Tort attorneys, free of charge, who can help assess any claims that you might have against Boehringer Ingelheim Pharmaceuticals, Inc.